Towards a Consensus Map for Cannabis Strain Names: Genomics for Authenticity, Certification and Oversight of the Cannabis Population

| Staff

THURSDAY, MAY 6 | 1:00pm (PDT) / 4:00pm (EDT)
Virtual Event (via Zoom)

EVENT DESCRIPTION

Towards a Consensus Map for Cannabis Strain Names:
Genomics for Authenticity, Certification and Oversight of the Cannabis Population

Join in this online discussion featuring Tim Harvey (Lighthouse Genomics) and Philippe Henry (Egret Bioscience) as they talk about Genomics for Authenticity, Certification and Oversight of the Cannabis Population related to Cannabis strains.

The discussion will be followed by a live Q&A for participants to engage in the conversation and get their genomics questions answered.

THE SPEAKERS

Timothy Harvey | CEO and Director, Lighthouse Genomics

Based on Salt Spring Island, BC, Tim has a background in Cannabis R&D, business leadership in private and public companies, public relations, intellectual property strategy and journalism. He founded Lighthouse Genomics to address the dual need for integrity in Cannabis supply chains and more widespread access to advanced genomics technologies. 

Philippe Henry | Founder, Egret Bioscience

Dr. Philippe Henry holds a doctoral degree in evolutionary genetics from the University of British Columbia, Master of Science and Bachelor of Science degrees from the University of Lausanne (Lausanne, Switzerland) and has served as an adjunct professor at the University of Northern British Columbia.

Widely published and a speaker on Cannabis science, Philippe was one of the first scientists to make discoveries of linkages between single nucleotide polymorphisms (SNPs) and Cannabis traits using the Lighthouse SNP array. Based in West Kelowna, Philippe is the founder of Egret Bioscience. Philippe is the visionary behind Egret’s transition to the psychedelic space, leveraging his expertise in cultivation, propagation, traceability and testing of controlled substances. 

From left to right: Timothy Harvey, Lighthouse Genomics; McKinley Hlady, CanTec Global; Dr. Steven Newmaster, NHP Research Alliance; Dr. Philippe Henry, Egret Bioscience.